Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 17;9(1):42.
doi: 10.1038/s41572-023-00452-3.

HIV infection

Affiliations
Review

HIV infection

Linda-Gail Bekker et al. Nat Rev Dis Primers. .

Erratum in

  • Author Correction: HIV infection.
    Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. Bekker LG, et al. Nat Rev Dis Primers. 2023 Sep 11;9(1):48. doi: 10.1038/s41572-023-00464-z. Nat Rev Dis Primers. 2023. PMID: 37696843 No abstract available.

Abstract

The AIDS epidemic has been a global public health issue for more than 40 years and has resulted in ~40 million deaths. AIDS is caused by the retrovirus, HIV-1, which is transmitted via body fluids and secretions. After infection, the virus invades host cells by attaching to CD4 receptors and thereafter one of two major chemokine coreceptors, CCR5 or CXCR4, destroying the host cell, most often a T lymphocyte, as it replicates. If unchecked this can lead to an immune-deficient state and demise over a period of ~2-10 years. The discovery and global roll-out of rapid diagnostics and effective antiretroviral therapy led to a large reduction in mortality and morbidity and to an expanding group of individuals requiring lifelong viral suppressive therapy. Viral suppression eliminates sexual transmission of the virus and greatly improves health outcomes. HIV infection, although still stigmatized, is now a chronic and manageable condition. Ultimate epidemic control will require prevention and treatment to be made available, affordable and accessible for all. Furthermore, the focus should be heavily oriented towards long-term well-being, care for multimorbidity and good quality of life. Intense research efforts continue for therapeutic and/or preventive vaccines, novel immunotherapies and a cure.

PubMed Disclaimer

References

    1. Djawe, K. et al. Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons—San Francisco, 1981–2012. J. Infect. Dis. 212, 1366–1375 (2015). - PubMed
    1. Violari, A. et al. Early antiretroviral therapy and mortality among HIV-infected infants. N. Engl. J. Med. 359, 2233–2244 (2008). - PubMed - PMC
    1. Garcia-Broncano, P. et al. Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile. Sci. Transl Med. 11, eaax7350 (2019). - PubMed - PMC
    1. Edwards, J. K. et al. Five-year mortality for adults entering human immunodeficiency virus care under universal early treatment compared with the general US population. Clin. Infect. Dis. 75, 867–874 (2022). - PubMed - PMC
    1. UNAIDS. UNAIDS Epidemiological Estimates. UNAIDS https://www.unaids.org/en/resources/documents/2023/2022_unaids_data (2022).

Publication types